Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NCH2 has now strung together ten consecutive sessions of rising short scores — and the latest reading, 97.3, is the highest the ORTEX composite has reached in the entire tracked history.
The borrow market remains the story. Availability has tightened back to roughly 1.7% — fewer than two shares available for every hundred already lent out — after a brief loosening to 6.5% on August 19 that proved short-lived. The lending pool is, for all practical purposes, exhausted. Cost to borrow has moderated from the wilder prints seen in late July and early August, when it touched 340% on July 31 and 339% on August 5, but it is still running at 152% — more than 50% above where it was just a week ago and more than five times the level from late June. That is not a market in recovery; it is a market oscillating at an extreme. The utilization rank and days-to-cover rank both sit at the bottom percentile of the ORTEX universe, reflected in factor scores of 1 for each.
The short score itself has now risen every single session since August 7, adding roughly 2.5 points over that stretch without a single pullback. A short score of 97.3 places nucera at the very top of bearish positioning signals across the universe ORTEX covers. The EPS momentum score for 30 days is an outlier at 99 — the highest possible reading — but that metric measures the direction of estimate revisions, not underlying profitability, and the 90-day momentum figure crashes back to 2. The analyst recommendation differential score of 93 reflects that the four buy-rated analysts are materially above consensus, with a mean price target of €10.52 against a current price of €7.83 — a gap of roughly 34%. That divergence between what analysts think the stock is worth and where it actually trades has been a feature of nucera for months, not a new development.
The ownership structure helps explain why the borrow market gets so congested so quickly. Thyssenkrupp Projekt 1 GmbH holds 50.2% of shares. Federico De Nora holds another 25.9%. The Public Investment Fund of Saudi Arabia holds 6%. That leaves a genuine free float of only around 18% — and it is that thin tradeable pool that short sellers are competing to borrow against. When demand for borrows is even moderately elevated, availability collapses fast and cost to borrow spikes violently, which is precisely what the history shows.
The stock itself slipped 1.1% over the past week to close at €7.83, continuing to drift near the lower end of the range it has held since earnings on August 12, when the stock fell 1.2% on the day and 2.6% over the following five sessions. The next scheduled earnings date is December 16. Peers were mixed on the week — AMRC on NYSE fell sharply, dropping 23% over the five sessions, while SCYR slipped 4.6%. Neither move appears directly connected to nucera.
The question going forward is whether cost to borrow continues its volatile oscillation around the 100–200% range or whether a meaningful reduction in short positioning forces it lower — something the near-zero availability makes structurally difficult to engineer without a catalyst.
See the live data behind this article on ORTEX.
Open NCH2 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
